Thu. Nov. 19, 2020 1:00 PM – 2:00 PM Register From accelerating clinical trials and gaining regulatory approval to expanding access and understanding market needs, this webinar will cover the basics of what makes real-world data regulatory and research grade and how it can transform your R&D and market access programs for autoimmune and other[…]
October 21, 2020- ISPOR In a recent blog post from ISPOR, Richard Gliklich, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 detail how Implementing Standardized Outcome Measures Supports Value-Based Care. Value-based care has received significant attention in recent years as an approach to improving patient outcomes while controlling healthcare costs.[…]
BOSTON, Sept. 21, 2020 /PRNewswire/ — An update of “Registries for Evaluating Patient Outcomes: A User’s Guide: 4th Edition,” was released today, the fourth edition of a reference handbook from the U.S. Agency for Healthcare Research and Quality (AHRQ) that contains practical information on the design, operation, and analysis of patient registries. First published in 2007, the User’s Guide[…]
Read the article: Leavy et al RWE for Cancer Screening PDS 2020
View our poster on Comparison of Symptoms, Treatments, and Healthcare Resource Utilization in Patients with Multiple Sclerosis by Sex in a Real-World Cohort in the United States. Click to view more!
